http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2690856-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0289b5c7b14585b669edc2580623cb4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-49 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 |
| filingDate | 2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_158c3c62faa9112109dacecfe1b5685f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c15fd652055dd9e4af7e828948247ed5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f77fdfbb1a022b5812587b36987438a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_407b89fae2febccae04e1fa67ee99bb4 |
| publicationDate | 2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2690856-C1 |
| titleOfInvention | Method for determining an anticoagulant potential of a vascular wall |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to laboratory diagnostics, and can be used to determine an anticoagulant potential of a vascular wall. That is ensured by double blood viscosity assessment by low-frequency piezocutaneous elastography (LPTEG) before and after dissolving an aliquot of whole blood 0.9 % with normal saline. Parameters of the LPTEG curve are determined: A1 1 – index of the minimum level of whole blood plasma LPTEG amplitude, where t1 1 is its reaching time; t3 1 is the time of achieving a gelation point in whole blood – the beginning of the fibrin polymerisation stage; A1 2 is an index of a minimum level of the curve of the LPTEG after adding an aliquot of whole blood to physiological solution, where t1 2 is its reaching time; t3 2 is the time of reaching the blood jellying point – the beginning of the fibrin polymerisation stage. If values A1 2 lower than A1 1 , and if value t1 2 , t3 2 greater than t1 1 , t3 1 anticoagulant potential of the vascular wall is defined as normal. If values A1 2 higher than A1 1 , and if value t1 2 , t3 2 less than t1 1 , t3 1 , anticoagulant potential of the vascular wall is defined as reduced. n EFFECT: invention enables determining the anticoagulant potential of a vascular wall in a patient. n 1 cl, 4 dwg, 2 ex |
| priorityDate | 2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.